TRENTAL (pentoxifylline) by Bausch Health is clinical pharmacology mode of action: pentoxifylline and its metabolites improve the flow properties of blood by decreasing its viscosity. First approved in 1984.
Drug data last refreshed 5h ago · AI intelligence enriched 1w ago
TRENTAL (pentoxifylline) is an oral small molecule that improves blood flow by decreasing blood viscosity and enhancing erythrocyte flexibility in patients with chronic peripheral arterial disease. It works by modifying leukocyte properties, increasing deformability, and inhibiting neutrophil adhesion to enhance tissue oxygenation. The precise mechanism of clinical improvement is still being defined, though hemorrheologic effects are well-established.
As a 40-year-old product approaching loss of exclusivity, the brand team is likely maintaining steady operations with modest resources allocated to retention and lifecycle management strategies.
CLINICAL PHARMACOLOGY Mode of Action: Pentoxifylline and its metabolites improve the flow properties of blood by decreasing its viscosity. In patients with chronic peripheral arterial disease, this increases blood flow to the affected microcirculation and enhances tissue oxygenation. The precise…
Worked on TRENTAL at Bausch Health? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation
Pentoxifylline as Anti-Inflammatory in Patients With Rheumatoid Arthritis
Bioequivalence Study of Pentoxifylline 400 Mg in Healthy Subjects Under Fasting and Fed Conditions
PentoxIfylline and Tocopherol for the Treatment of Post-radiotherapy Fibrosis in Head and Neck Cancer Patients
Pentoxifylline Effect in Patients With Diabetic Nephropathy.(PENFOSIDINE STUDY)
Working on TRENTAL as a pharma professional means joining a mature, defensive portfolio requiring retention strategies rather than growth initiatives. This is best suited for experienced professionals managing LOE transition or early-career professionals seeking to learn lifecycle management in a lower-risk environment.